SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM) -- Ignore unavailable to you. Want to Upgrade?


To: Icebrg who wrote (2099)4/29/2004 11:46:40 AM
From: Icebrg  Read Replies (2) | Respond to of 3044
 
Millennium Pharmaceuticals downgraded to "market perform"

Wednesday, April 28, 2004 11:05:00 AM ET
Friedman,Billings,Ramsey &Co

NEW YORK, April 28 (New Ratings) - Analysts at Friedman Billings downgrade Millennium Pharmaceuticals (MLNM.NAS) from "outperform" to "market perform." The target price has been reduced from $20 to $16.